" class="no-js "lang="en-US"> Mission Bio - Medtech Alert
Thursday, March 30, 2023

Breaking News

Nanoscope Therapeutics Announces Positive Topline Results from Phase 2b RESTORE Trial of MCO-010 for the Treatment of Retinitis Pigmentosa Glyscend Therapeutics Appoints Biotech Industry Veteran Michael Wyzga to its Board of Directors Trobix Bio Raises $3 Million from Chartered Group to Advance Precision Microbiome Oncology Therapeutics Mathai Mammen to Join FogPharma as Chairman, President and Chief Executive Officer Confo Therapeutics Enters into Collaboration Agreement with Daiichi Sankyo to Discover Novel Medicines for CNS Diseases Implantica Launches RefluxStop™ in Italy Granular Therapeutics to Accelerate Development of Next-Generation Pipeline for Treating Mast Cell Driven Diseases Xeris Biopharma Appoints Ricki Fairley to Board of Directors AskBio to Present Phase 1b Results Investigating AB-1005 as Treatment for Parkinson’s Disease New Imaging Method for Evaluating Transport of Oxygen to Blood Cells
Mission Bio | Pharmtech Focus

Mission Bio

About Mission Bio

Mission Bio

Mission Bio is a company of passionate people dedicated to solving complex biological problems with precision engineering, innovative biochemistry, and supported bioinformatics.

In 2014, the company was spun out of Adam Abate’s lab for high-throughput biology at the University of California, San Francisco (UCSF). Mission Bio’s precision genomics platform is based on the pioneering droplet microfluidics work of Abate and his team.

Our mission is to help researchers and clinicians unlock single-cell biology to enable the discovery, development, and delivery of precision medicine.

Visit missionbio.com to learn more.

Related Story

Clinical Trials

 Mission Bio and Abiosciences Partner to Co-develop Bioinformatics for Clinical Research Applications in China | PTF

Mission Bio and Abiosciences Partner to Co-develop Bioinformatics for Clinical Research Applications in China

January 3 2023

Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, and Abiosciences, the single-cell […]

Diseases

 IDIBAPS Researchers Discover Genetic Drivers of Clonal Evolution in Leukemia Using Single-Cell DNA Sequencing from Mission Bio | Pharmtech Focus

IDIBAPS Researchers Discover Genetic Drivers of Clonal Evolution in Leukemia Using Single-Cell DNA Sequencing from Mission Bio

August 12 2022

Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, announced new findings from […]

Diseases

 Sequanta and Mission Bio Announce Strategic Partnership | Pharmtech Focus

Sequanta and Mission Bio Announce Strategic Partnership

July 9 2021

Sequanta Technologies Co., Ltd. and Mission Bio are pleased to announce that they have entered […]